A PRospective evaluation of impact of additional Imaging modalities in Surgical Management and outcome in Treatment naive breast Cancer patients.

This prospective interventional study is designed to evaluate the role of additional pre-operative imaging modalities Magnetic Resonance Imaging (MRI) and Contrast-Enhanced Mammography (CEM) in optimizing the surgical management of treatmen naive breast cancer patients. Eligible patients with newly diagnosed, biopsy confirmed invasive breast cancer who have not received any prior treatment will first undergo standard imaging workup including mammography and ultrasound. Subsequently, participants will receive MRI and/or CEM within two weeks prior to planned surgery. The surgical team will use all imaging data to determine the extent and type of surgery needed. The study aims to assess how MRI and CEM influence surgical decision making by measuring changes in surgical plans, additional lesion detection rates, and the concordance between imaging findings and final histopathology. Post-operative outcomes including margin status, reoperation rates, and complications will be documented. Follow-up assessments will be conducted up to three months after surgery to monitor patient recovery and surgical efficacy. The study seeks to provide evidence on whether incorporating MRI and CEM improves surgical outcomes and patient management in breast cancer care.